The Scientist

» African American

Most Recent

image: On Race, Gender, and NIH Funding

On Race, Gender, and NIH Funding

By | August 1, 2016

The results of two studies suggest slightly different biases in the review of National Institutes of Health R01 grant applications from minority and/or women researchers.

0 Comments

image: Telomeres Show Signs of Early-Life Stress

Telomeres Show Signs of Early-Life Stress

By | April 7, 2014

Reduction in telomere length is associated with stress early on in life and may have a genetic component, researchers find.

4 Comments

image: Opinion: A Diverse Perspective

Opinion: A Diverse Perspective

By | July 29, 2013

Progress in science is dependent on the diversity of its workforce.

3 Comments

image: Opinion: On Being an “African-American Scientist”

Opinion: On Being an “African-American Scientist”

By | March 5, 2013

If African-American researchers are ever to gain equal opportunities in science, even subtle cases of differential treatment must be stamped out.

15 Comments

image: NIH Tackles Racism

NIH Tackles Racism

By | June 25, 2012

An advisory committee urges the federal funding agency to take steps to counter racial bias in the granting process.

2 Comments

image: NIH Biased Against Blacks?

NIH Biased Against Blacks?

By | August 22, 2011

A new study reveals that African American researchers are 10 percent less likely to receive funding from the federal agency than their white peers.

39 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham